Screener/Healthcare/Biotechnology

KRYS

Krystal Biotech, Inc.NASDAQ
$256.26+9.17 (+3.71%)
Mid CapHealthcareFastest GrowingLow BetaMost Profitable
$122.80
$298.30
$250.91
$257.65
EPS (TTM)$6.85
P/E Ratio36.17
Dividend Yield—
Market Cap$7.54B
Volume13K
Prev Close$247.09
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$107.1M$51.4M$1.70—48.0%
Q3 '25$97.8M$79.4M$2.66—81.2%
Q2 '25$96.0M$38.3M$1.29—39.9%
Q1 '25$88.2M$35.7M$1.20—40.5%
Q3 '24$83.8M$27.2M$0.91—32.4%
Q2 '24$70.3M$15.6M$0.53—22.2%
Q1 '24$45.3M$932K$0.03—2.1%
Q4 '23$42.1M$8.7M$0.31—20.6%
Get Your Daily Market Recap